We previously identified three homogeneous DNA methylation-based subgroups of PCCs/PGLs: the M1 group corresponding to SDHx- and FH-mutated cases and displaying a hypermethylator phenotype, the M2 group comprising exclusively VHL-mutated samples and the M3 group comprising mostly tumours of the C2 expression cluster. This evidence concerns the gene FH and neoplasm.